17 research outputs found
Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors)
Objective To describe the clinical and sonographic
characteristics of malignant ovarian yolk sac tumors
(YSTs).
Methods In this retrospective multicenter study, we
included 21 patients with a histological diagnosis of
ovarian YST and available transvaginal ultrasound
images and/or videoclips and/or a detailed ultrasound
report. Ten patients identified from the International Results All cases were pure YSTs, except for one that
was a mixed tumor (80% YST and 20% embryonal
carcinoma). Median age at diagnosis was 25 (interquartile
range (IQR), 19.5–30.5) years. Seventy-six percent
(16/21) of women had an International Federation of
Gynecology and Obstetrics (FIGO) Stage I–II tumor at
diagnosis. Fifty-eight percent (11/19) of women felt pain
during the ultrasound examination and one presented
with ovarian torsion. Median serum α-fetoprotein (S-AFP)
level was 4755 (IQR, 1071–25 303) μg/L and median
serum CA 125 level was 126 (IQR, 35–227) kU/L. On
ultrasound assessment, 95% (20/21) of tumors were
unilateral. The median maximum tumor diameter was
157 (IQR, 107–181) mm and the largest solid component
was 110 (IQR, 66–159) mm. Tumors were classified as either multilocular-solid (10/21; 48%) or solid (11/21;
52%). Papillary projections were found in 10% (2/21) of
cases. Most (20/21; 95%) tumors were well vascularized
(color score, 3–4) and none had acoustic shadowing.
Malignancy was suspected in all cases, except in the
patient with ovarian torsion, who presented a tumor with
a color score of 1, which was classified as probably benign.
Image and videoclip quality was considered as adequate
in 18/21 cases. On review of the images and videoclips, we
found that all tumors contained both solid components
and cystic spaces, and that 89% (16/18) had irregular, still
fine-textured and slightly hyperechoic solid tissue, giving
them a characteristic appearance.
Conclusion Malignant ovarian YSTs are often detected
at an early stage, in young women usually in the second
or third decade of life, presenting with pain and markedly
elevated S-AFP. On ultrasound, malignant ovarian YSTs
are mostly unilateral, large and multilocular-solid or solid,
with fine-textured slightly hyperechoic solid tissue and
rich vascularization. © 2020 The Authors. Ultrasound
in Obstetrics & Gynecology published by John Wiley
& Sons Ltd on behalf of the International Society of
Ultrasound in Obstetrics and Gynecology
Liquid crystals and their defects
These lecture notes discuss classical models of liquid crystals, and the
different ways in which defects are described according to the different
models.Comment: CIME lecture course, Cetraro, 201
Comparative effects of 17β-estradiol and phytoestrogens in the regulation of endometrial functions in the rodent uterus
The present study aimed at improving our understanding of the effects of 17beta-estradiol and phytoestrogens on the uterine tissue, by evaluating tissue-specific modulation of molecules related to cell-cycle control and angiogenesis. Specifically, the uterine expression of Ki67, peroxisome proliferator-activated receptor gamma (PPARgamma), and vascular endothelial growth factor receptor-2 (VEGFR-2), was examined by immunohistochemical analysis. Ovariectomized (OVX) rats were treated with either the vehicle, a phytoestrogen- containing soy extract (SSE) (100 mg/kg/day pos), or 17beta-estradiol (0.5 mg/kg/day pos); a sham control group (SHAM) was also included in the study. At necropsy, uteri were weighed, collected, and subsequently processed for histopathology or immunohistochemistry. SSE-treated rats did not show any significant change either in the weight or in histological features of the uterus when compared to OVX controls; the epithelial expression of proliferation marker Ki67 was seen to be significantly reduced, in comparison to both SHAM and OVX rats. Conversely, 17beta-estradiol significantly increased uterine weight, induced hyperplasia in the majority of rats, and enhanced Ki67 epithelial expression. The regulation of PPARgamma expression, reduced after ovariectomy, was similar in SSE- and 17beta-estradiol-treated rats, showing a further significant decrease in stromal immunostaining, in comparison to OVX controls. VEGFR-2 epithelial immunostaining, slightly reduced following ovariectomy, was highly increased on 17beta-estradiol treatment, while following SSE, the pattern of staining observed was similar to that of OVX controls. Data from this study show that PPARgamma and VEGFR-2 represent additional targets by which sex steroid estrogen and plant-derived phytoestrogens may, at certain doses, differentially regulate endometrial functions
Imaging in gynecological disease (17): ultrasound features of malignant ovarian yolk sac tumors (endodermal sinus tumors)
Objective To describe the clinical and sonographic
characteristics of malignant ovarian yolk sac tumors
(YSTs).
Methods In this retrospective multicenter study, we
included 21 patients with a histological diagnosis of
ovarian YST and available transvaginal ultrasound
images and/or videoclips and/or a detailed ultrasound
report. Ten patients identified from the International Results All cases were pure YSTs, except for one that
was a mixed tumor (80% YST and 20% embryonal
carcinoma). Median age at diagnosis was 25 (interquartile
range (IQR), 19.5–30.5) years. Seventy-six percent
(16/21) of women had an International Federation of
Gynecology and Obstetrics (FIGO) Stage I–II tumor at
diagnosis. Fifty-eight percent (11/19) of women felt pain
during the ultrasound examination and one presented
with ovarian torsion. Median serum α-fetoprotein (S-AFP)
level was 4755 (IQR, 1071–25 303) μg/L and median
serum CA 125 level was 126 (IQR, 35–227) kU/L. On
ultrasound assessment, 95% (20/21) of tumors were
unilateral. The median maximum tumor diameter was
157 (IQR, 107–181) mm and the largest solid component
was 110 (IQR, 66–159) mm. Tumors were classified as either multilocular-solid (10/21; 48%) or solid (11/21;
52%). Papillary projections were found in 10% (2/21) of
cases. Most (20/21; 95%) tumors were well vascularized
(color score, 3–4) and none had acoustic shadowing.
Malignancy was suspected in all cases, except in the
patient with ovarian torsion, who presented a tumor with
a color score of 1, which was classified as probably benign.
Image and videoclip quality was considered as adequate
in 18/21 cases. On review of the images and videoclips, we
found that all tumors contained both solid components
and cystic spaces, and that 89% (16/18) had irregular, still
fine-textured and slightly hyperechoic solid tissue, giving
them a characteristic appearance.
Conclusion Malignant ovarian YSTs are often detected
at an early stage, in young women usually in the second
or third decade of life, presenting with pain and markedly
elevated S-AFP. On ultrasound, malignant ovarian YSTs
are mostly unilateral, large and multilocular-solid or solid,
with fine-textured slightly hyperechoic solid tissue and
rich vascularization. © 2020 The Authors. Ultrasound
in Obstetrics & Gynecology published by John Wiley
& Sons Ltd on behalf of the International Society of
Ultrasound in Obstetrics and Gynecology
Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer
Introduction: Growing evidence in the literature supports the accuracy of sentinel lymph node (SLN) biopsy in early-stage cervical cancer. One-step nucleic acid amplification (OSNA) is a rapid assay able to detect cytokeratin 19-mRNA in SLNs, and it can be used for intra-operative detection of low-volume metastases. The aim of this study was to evaluate the rate of low-volume metastasis in SLNs detected by OSNA in patients with early-stage cervical cancer. Secondary aims were to define the sensitivity and the negative predictive value of SLN biopsy assessed with OSNA. Methods: After IRB approval, consecutive patients who underwent surgery for International Federation of Gynecology and Obstetrics stage IA1 with lymph-vascular space involvement to IB1 between November 2017 and July 2019 and had SLN biopsy and pelvic lymphadenectomy were included. SLNs were detected with indocyanine-green cervical injection and sent intra-operatively for OSNA. Results: Eighteen patients underwent SLN assessment with OSNA and systematic pelvic lymphadenectomy in the study period. Four (22.2%) patients had unilateral and 14 (77.8%) had bilateral mapping. OSNA detected micro-metastasis in 6/18 (33.3%) patients. All micro-metastases were detected in patients with bilateral SLN mapping. The sensitivity and negative predictive value of SLN in detecting lymph node metastasis with OSNA calculated per pelvic sidewall were 85.7% and 96.1%, respectively. The false negative rate in mapped sidewalls was 14.3%. Discussion: This is the first series entirely processing SLNs for OSNA in early-stage cervical cancer. OSNA is able to intra-operatively detect low-volume metastases in SLNs. Further studies are necessary to confirm the accuracy of this technique and to assess survival implications of low-volume metastases detected by OSNA